nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2C19—Gefitinib—lung cancer	0.045	0.0744	CbGbCtD
Efavirenz—CYP2C19—Teniposide—lung cancer	0.0437	0.0721	CbGbCtD
Efavirenz—CYP2B6—Irinotecan—lung cancer	0.0378	0.0625	CbGbCtD
Efavirenz—CYP2C9—Gefitinib—lung cancer	0.0374	0.0618	CbGbCtD
Efavirenz—CYP2C9—Teniposide—lung cancer	0.0363	0.06	CbGbCtD
Efavirenz—CYP2D6—Gefitinib—lung cancer	0.0342	0.0565	CbGbCtD
Efavirenz—CYP2B6—Cisplatin—lung cancer	0.0308	0.051	CbGbCtD
Efavirenz—CYP2D6—Vinorelbine—lung cancer	0.0264	0.0436	CbGbCtD
Efavirenz—CYP1A2—Erlotinib—lung cancer	0.0246	0.0406	CbGbCtD
Efavirenz—CYP3A4—Topotecan—lung cancer	0.0238	0.0393	CbGbCtD
Efavirenz—CYP3A4—Gefitinib—lung cancer	0.0218	0.036	CbGbCtD
Efavirenz—CYP3A4—Teniposide—lung cancer	0.0211	0.0349	CbGbCtD
Efavirenz—CYP2B6—Doxorubicin—lung cancer	0.0207	0.0341	CbGbCtD
Efavirenz—CYP2C9—Paclitaxel—lung cancer	0.0203	0.0335	CbGbCtD
Efavirenz—CYP2D6—Erlotinib—lung cancer	0.0202	0.0334	CbGbCtD
Efavirenz—CYP1A2—Etoposide—lung cancer	0.0178	0.0294	CbGbCtD
Efavirenz—CYP3A4—Vinorelbine—lung cancer	0.0168	0.0277	CbGbCtD
Efavirenz—CYP2C9—Cisplatin—lung cancer	0.0163	0.0269	CbGbCtD
Efavirenz—CYP2D6—Vinblastine—lung cancer	0.0162	0.0268	CbGbCtD
Efavirenz—CYP3A4—Crizotinib—lung cancer	0.0133	0.022	CbGbCtD
Efavirenz—CYP3A4—Erlotinib—lung cancer	0.0129	0.0213	CbGbCtD
Efavirenz—CYP3A4—Paclitaxel—lung cancer	0.0118	0.0195	CbGbCtD
Efavirenz—CYP3A4—Irinotecan—lung cancer	0.0116	0.0192	CbGbCtD
Efavirenz—CYP3A4—Vinblastine—lung cancer	0.0103	0.0171	CbGbCtD
Efavirenz—CYP2D6—Doxorubicin—lung cancer	0.00998	0.0165	CbGbCtD
Efavirenz—CYP3A4—Etoposide—lung cancer	0.00931	0.0154	CbGbCtD
Efavirenz—CYP3A4—Docetaxel—lung cancer	0.00852	0.0141	CbGbCtD
Efavirenz—CYP3A4—Doxorubicin—lung cancer	0.00635	0.0105	CbGbCtD
Efavirenz—Gastrointestinal disorder—Etoposide—lung cancer	9.45e-05	0.000331	CcSEcCtD
Efavirenz—Dyspepsia—Paclitaxel—lung cancer	9.45e-05	0.000331	CcSEcCtD
Efavirenz—Body temperature increased—Cisplatin—lung cancer	9.45e-05	0.000331	CcSEcCtD
Efavirenz—Asthenia—Irinotecan—lung cancer	9.44e-05	0.000331	CcSEcCtD
Efavirenz—Fatigue—Etoposide—lung cancer	9.44e-05	0.00033	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	9.43e-05	0.00033	CcSEcCtD
Efavirenz—Constipation—Etoposide—lung cancer	9.36e-05	0.000328	CcSEcCtD
Efavirenz—Pain—Etoposide—lung cancer	9.36e-05	0.000328	CcSEcCtD
Efavirenz—Decreased appetite—Paclitaxel—lung cancer	9.33e-05	0.000327	CcSEcCtD
Efavirenz—Dry mouth—Docetaxel—lung cancer	9.28e-05	0.000325	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Doxorubicin—lung cancer	9.28e-05	0.000325	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Paclitaxel—lung cancer	9.27e-05	0.000324	CcSEcCtD
Efavirenz—Fatigue—Paclitaxel—lung cancer	9.25e-05	0.000324	CcSEcCtD
Efavirenz—Hepatitis—Methotrexate—lung cancer	9.23e-05	0.000323	CcSEcCtD
Efavirenz—Asthenia—Gemcitabine—lung cancer	9.2e-05	0.000322	CcSEcCtD
Efavirenz—Pain—Paclitaxel—lung cancer	9.18e-05	0.000321	CcSEcCtD
Efavirenz—Constipation—Paclitaxel—lung cancer	9.18e-05	0.000321	CcSEcCtD
Efavirenz—Confusional state—Docetaxel—lung cancer	9.17e-05	0.000321	CcSEcCtD
Efavirenz—Urinary tract disorder—Methotrexate—lung cancer	9.12e-05	0.000319	CcSEcCtD
Efavirenz—Photosensitivity reaction—Doxorubicin—lung cancer	9.11e-05	0.000319	CcSEcCtD
Efavirenz—Pruritus—Gemcitabine—lung cancer	9.07e-05	0.000318	CcSEcCtD
Efavirenz—Urethral disorder—Methotrexate—lung cancer	9.05e-05	0.000317	CcSEcCtD
Efavirenz—Feeling abnormal—Etoposide—lung cancer	9.02e-05	0.000316	CcSEcCtD
Efavirenz—Hyperglycaemia—Doxorubicin—lung cancer	9.01e-05	0.000315	CcSEcCtD
Efavirenz—Diarrhoea—Irinotecan—lung cancer	9.01e-05	0.000315	CcSEcCtD
Efavirenz—Pneumonia—Doxorubicin—lung cancer	8.96e-05	0.000314	CcSEcCtD
Efavirenz—Gastrointestinal pain—Etoposide—lung cancer	8.95e-05	0.000313	CcSEcCtD
Efavirenz—Shock—Docetaxel—lung cancer	8.95e-05	0.000313	CcSEcCtD
Efavirenz—Nervous system disorder—Docetaxel—lung cancer	8.92e-05	0.000312	CcSEcCtD
Efavirenz—Thrombocytopenia—Docetaxel—lung cancer	8.91e-05	0.000312	CcSEcCtD
Efavirenz—Infestation—Doxorubicin—lung cancer	8.9e-05	0.000312	CcSEcCtD
Efavirenz—Infestation NOS—Doxorubicin—lung cancer	8.9e-05	0.000312	CcSEcCtD
Efavirenz—Drowsiness—Doxorubicin—lung cancer	8.9e-05	0.000312	CcSEcCtD
Efavirenz—Visual impairment—Methotrexate—lung cancer	8.9e-05	0.000311	CcSEcCtD
Efavirenz—Tachycardia—Docetaxel—lung cancer	8.88e-05	0.000311	CcSEcCtD
Efavirenz—Feeling abnormal—Paclitaxel—lung cancer	8.85e-05	0.00031	CcSEcCtD
Efavirenz—Skin disorder—Docetaxel—lung cancer	8.84e-05	0.000309	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Doxorubicin—lung cancer	8.83e-05	0.000309	CcSEcCtD
Efavirenz—Hypersensitivity—Cisplatin—lung cancer	8.8e-05	0.000308	CcSEcCtD
Efavirenz—Gastrointestinal pain—Paclitaxel—lung cancer	8.78e-05	0.000307	CcSEcCtD
Efavirenz—Diarrhoea—Gemcitabine—lung cancer	8.77e-05	0.000307	CcSEcCtD
Efavirenz—Renal failure—Doxorubicin—lung cancer	8.75e-05	0.000306	CcSEcCtD
Efavirenz—Erythema multiforme—Methotrexate—lung cancer	8.73e-05	0.000306	CcSEcCtD
Efavirenz—Neuropathy peripheral—Doxorubicin—lung cancer	8.73e-05	0.000306	CcSEcCtD
Efavirenz—Dizziness—Irinotecan—lung cancer	8.7e-05	0.000305	CcSEcCtD
Efavirenz—Urticaria—Etoposide—lung cancer	8.7e-05	0.000305	CcSEcCtD
Efavirenz—Jaundice—Doxorubicin—lung cancer	8.68e-05	0.000304	CcSEcCtD
Efavirenz—Anorexia—Docetaxel—lung cancer	8.67e-05	0.000304	CcSEcCtD
Efavirenz—Abdominal pain—Etoposide—lung cancer	8.65e-05	0.000303	CcSEcCtD
Efavirenz—Body temperature increased—Etoposide—lung cancer	8.65e-05	0.000303	CcSEcCtD
Efavirenz—Eye disorder—Methotrexate—lung cancer	8.63e-05	0.000302	CcSEcCtD
Efavirenz—Tinnitus—Methotrexate—lung cancer	8.61e-05	0.000301	CcSEcCtD
Efavirenz—Asthenia—Cisplatin—lung cancer	8.57e-05	0.0003	CcSEcCtD
Efavirenz—Cardiac disorder—Methotrexate—lung cancer	8.57e-05	0.0003	CcSEcCtD
Efavirenz—Sweating—Doxorubicin—lung cancer	8.54e-05	0.000299	CcSEcCtD
Efavirenz—Urticaria—Paclitaxel—lung cancer	8.53e-05	0.000299	CcSEcCtD
Efavirenz—Haematuria—Doxorubicin—lung cancer	8.49e-05	0.000297	CcSEcCtD
Efavirenz—Abdominal pain—Paclitaxel—lung cancer	8.49e-05	0.000297	CcSEcCtD
Efavirenz—Body temperature increased—Paclitaxel—lung cancer	8.49e-05	0.000297	CcSEcCtD
Efavirenz—Hepatobiliary disease—Doxorubicin—lung cancer	8.42e-05	0.000295	CcSEcCtD
Efavirenz—Angiopathy—Methotrexate—lung cancer	8.37e-05	0.000293	CcSEcCtD
Efavirenz—Vomiting—Irinotecan—lung cancer	8.37e-05	0.000293	CcSEcCtD
Efavirenz—Sinusitis—Doxorubicin—lung cancer	8.35e-05	0.000292	CcSEcCtD
Efavirenz—Immune system disorder—Methotrexate—lung cancer	8.34e-05	0.000292	CcSEcCtD
Efavirenz—Mediastinal disorder—Methotrexate—lung cancer	8.32e-05	0.000291	CcSEcCtD
Efavirenz—Rash—Irinotecan—lung cancer	8.3e-05	0.000291	CcSEcCtD
Efavirenz—Dermatitis—Irinotecan—lung cancer	8.29e-05	0.00029	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Docetaxel—lung cancer	8.29e-05	0.00029	CcSEcCtD
Efavirenz—Headache—Irinotecan—lung cancer	8.25e-05	0.000289	CcSEcCtD
Efavirenz—Insomnia—Docetaxel—lung cancer	8.23e-05	0.000288	CcSEcCtD
Efavirenz—Diarrhoea—Cisplatin—lung cancer	8.18e-05	0.000286	CcSEcCtD
Efavirenz—Paraesthesia—Docetaxel—lung cancer	8.17e-05	0.000286	CcSEcCtD
Efavirenz—Alopecia—Methotrexate—lung cancer	8.16e-05	0.000286	CcSEcCtD
Efavirenz—Vomiting—Gemcitabine—lung cancer	8.15e-05	0.000285	CcSEcCtD
Efavirenz—Dyspnoea—Docetaxel—lung cancer	8.11e-05	0.000284	CcSEcCtD
Efavirenz—Somnolence—Docetaxel—lung cancer	8.09e-05	0.000283	CcSEcCtD
Efavirenz—Rash—Gemcitabine—lung cancer	8.08e-05	0.000283	CcSEcCtD
Efavirenz—Dermatitis—Gemcitabine—lung cancer	8.08e-05	0.000283	CcSEcCtD
Efavirenz—Hypersensitivity—Etoposide—lung cancer	8.07e-05	0.000282	CcSEcCtD
Efavirenz—Erythema—Methotrexate—lung cancer	8.04e-05	0.000281	CcSEcCtD
Efavirenz—Malnutrition—Methotrexate—lung cancer	8.04e-05	0.000281	CcSEcCtD
Efavirenz—Headache—Gemcitabine—lung cancer	8.03e-05	0.000281	CcSEcCtD
Efavirenz—Rhinitis—Doxorubicin—lung cancer	8.01e-05	0.000281	CcSEcCtD
Efavirenz—Dyspepsia—Docetaxel—lung cancer	8.01e-05	0.00028	CcSEcCtD
Efavirenz—Hepatitis—Doxorubicin—lung cancer	7.99e-05	0.00028	CcSEcCtD
Efavirenz—Hypoaesthesia—Doxorubicin—lung cancer	7.95e-05	0.000278	CcSEcCtD
Efavirenz—Decreased appetite—Docetaxel—lung cancer	7.91e-05	0.000277	CcSEcCtD
Efavirenz—Hypersensitivity—Paclitaxel—lung cancer	7.91e-05	0.000277	CcSEcCtD
Efavirenz—Urinary tract disorder—Doxorubicin—lung cancer	7.89e-05	0.000276	CcSEcCtD
Efavirenz—Oedema peripheral—Doxorubicin—lung cancer	7.87e-05	0.000276	CcSEcCtD
Efavirenz—Dysgeusia—Methotrexate—lung cancer	7.87e-05	0.000275	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Docetaxel—lung cancer	7.86e-05	0.000275	CcSEcCtD
Efavirenz—Asthenia—Etoposide—lung cancer	7.86e-05	0.000275	CcSEcCtD
Efavirenz—Connective tissue disorder—Doxorubicin—lung cancer	7.85e-05	0.000275	CcSEcCtD
Efavirenz—Fatigue—Docetaxel—lung cancer	7.84e-05	0.000275	CcSEcCtD
Efavirenz—Urethral disorder—Doxorubicin—lung cancer	7.83e-05	0.000274	CcSEcCtD
Efavirenz—Nausea—Irinotecan—lung cancer	7.82e-05	0.000274	CcSEcCtD
Efavirenz—Pain—Docetaxel—lung cancer	7.78e-05	0.000272	CcSEcCtD
Efavirenz—Constipation—Docetaxel—lung cancer	7.78e-05	0.000272	CcSEcCtD
Efavirenz—Back pain—Methotrexate—lung cancer	7.77e-05	0.000272	CcSEcCtD
Efavirenz—Pruritus—Etoposide—lung cancer	7.75e-05	0.000271	CcSEcCtD
Efavirenz—Visual impairment—Doxorubicin—lung cancer	7.7e-05	0.00027	CcSEcCtD
Efavirenz—Asthenia—Paclitaxel—lung cancer	7.7e-05	0.00027	CcSEcCtD
Efavirenz—Nausea—Gemcitabine—lung cancer	7.62e-05	0.000267	CcSEcCtD
Efavirenz—Vomiting—Cisplatin—lung cancer	7.6e-05	0.000266	CcSEcCtD
Efavirenz—Pruritus—Paclitaxel—lung cancer	7.59e-05	0.000266	CcSEcCtD
Efavirenz—Vision blurred—Methotrexate—lung cancer	7.57e-05	0.000265	CcSEcCtD
Efavirenz—Erythema multiforme—Doxorubicin—lung cancer	7.56e-05	0.000265	CcSEcCtD
Efavirenz—Rash—Cisplatin—lung cancer	7.54e-05	0.000264	CcSEcCtD
Efavirenz—Dermatitis—Cisplatin—lung cancer	7.53e-05	0.000264	CcSEcCtD
Efavirenz—Feeling abnormal—Docetaxel—lung cancer	7.5e-05	0.000263	CcSEcCtD
Efavirenz—Diarrhoea—Etoposide—lung cancer	7.49e-05	0.000262	CcSEcCtD
Efavirenz—Eye disorder—Doxorubicin—lung cancer	7.47e-05	0.000262	CcSEcCtD
Efavirenz—Ill-defined disorder—Methotrexate—lung cancer	7.46e-05	0.000261	CcSEcCtD
Efavirenz—Tinnitus—Doxorubicin—lung cancer	7.45e-05	0.000261	CcSEcCtD
Efavirenz—Gastrointestinal pain—Docetaxel—lung cancer	7.44e-05	0.00026	CcSEcCtD
Efavirenz—Anaemia—Methotrexate—lung cancer	7.43e-05	0.00026	CcSEcCtD
Efavirenz—Cardiac disorder—Doxorubicin—lung cancer	7.42e-05	0.00026	CcSEcCtD
Efavirenz—Flushing—Doxorubicin—lung cancer	7.42e-05	0.00026	CcSEcCtD
Efavirenz—Diarrhoea—Paclitaxel—lung cancer	7.34e-05	0.000257	CcSEcCtD
Efavirenz—Angiopathy—Doxorubicin—lung cancer	7.25e-05	0.000254	CcSEcCtD
Efavirenz—Malaise—Methotrexate—lung cancer	7.25e-05	0.000254	CcSEcCtD
Efavirenz—Dizziness—Etoposide—lung cancer	7.24e-05	0.000253	CcSEcCtD
Efavirenz—Immune system disorder—Doxorubicin—lung cancer	7.22e-05	0.000253	CcSEcCtD
Efavirenz—Vertigo—Methotrexate—lung cancer	7.22e-05	0.000253	CcSEcCtD
Efavirenz—Mediastinal disorder—Doxorubicin—lung cancer	7.2e-05	0.000252	CcSEcCtD
Efavirenz—Abdominal pain—Docetaxel—lung cancer	7.19e-05	0.000252	CcSEcCtD
Efavirenz—Body temperature increased—Docetaxel—lung cancer	7.19e-05	0.000252	CcSEcCtD
Efavirenz—Arrhythmia—Doxorubicin—lung cancer	7.14e-05	0.00025	CcSEcCtD
Efavirenz—Dizziness—Paclitaxel—lung cancer	7.1e-05	0.000249	CcSEcCtD
Efavirenz—Nausea—Cisplatin—lung cancer	7.1e-05	0.000249	CcSEcCtD
Efavirenz—Alopecia—Doxorubicin—lung cancer	7.06e-05	0.000247	CcSEcCtD
Efavirenz—Cough—Methotrexate—lung cancer	7.01e-05	0.000245	CcSEcCtD
Efavirenz—Convulsion—Methotrexate—lung cancer	6.96e-05	0.000244	CcSEcCtD
Efavirenz—Vomiting—Etoposide—lung cancer	6.96e-05	0.000244	CcSEcCtD
Efavirenz—Malnutrition—Doxorubicin—lung cancer	6.96e-05	0.000244	CcSEcCtD
Efavirenz—Erythema—Doxorubicin—lung cancer	6.96e-05	0.000244	CcSEcCtD
Efavirenz—Rash—Etoposide—lung cancer	6.9e-05	0.000242	CcSEcCtD
Efavirenz—Dermatitis—Etoposide—lung cancer	6.9e-05	0.000241	CcSEcCtD
Efavirenz—Headache—Etoposide—lung cancer	6.86e-05	0.00024	CcSEcCtD
Efavirenz—Flatulence—Doxorubicin—lung cancer	6.86e-05	0.00024	CcSEcCtD
Efavirenz—Chest pain—Methotrexate—lung cancer	6.84e-05	0.000239	CcSEcCtD
Efavirenz—Myalgia—Methotrexate—lung cancer	6.84e-05	0.000239	CcSEcCtD
Efavirenz—Arthralgia—Methotrexate—lung cancer	6.84e-05	0.000239	CcSEcCtD
Efavirenz—Tension—Doxorubicin—lung cancer	6.83e-05	0.000239	CcSEcCtD
Efavirenz—Vomiting—Paclitaxel—lung cancer	6.83e-05	0.000239	CcSEcCtD
Efavirenz—Dysgeusia—Doxorubicin—lung cancer	6.81e-05	0.000239	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	6.79e-05	0.000238	CcSEcCtD
Efavirenz—Rash—Paclitaxel—lung cancer	6.77e-05	0.000237	CcSEcCtD
Efavirenz—Dermatitis—Paclitaxel—lung cancer	6.76e-05	0.000237	CcSEcCtD
Efavirenz—Discomfort—Methotrexate—lung cancer	6.76e-05	0.000237	CcSEcCtD
Efavirenz—Nervousness—Doxorubicin—lung cancer	6.76e-05	0.000237	CcSEcCtD
Efavirenz—Back pain—Doxorubicin—lung cancer	6.73e-05	0.000236	CcSEcCtD
Efavirenz—Headache—Paclitaxel—lung cancer	6.72e-05	0.000235	CcSEcCtD
Efavirenz—Hypersensitivity—Docetaxel—lung cancer	6.7e-05	0.000235	CcSEcCtD
Efavirenz—Confusional state—Methotrexate—lung cancer	6.61e-05	0.000231	CcSEcCtD
Efavirenz—Vision blurred—Doxorubicin—lung cancer	6.56e-05	0.00023	CcSEcCtD
Efavirenz—Asthenia—Docetaxel—lung cancer	6.53e-05	0.000229	CcSEcCtD
Efavirenz—Nausea—Etoposide—lung cancer	6.5e-05	0.000228	CcSEcCtD
Efavirenz—Ill-defined disorder—Doxorubicin—lung cancer	6.46e-05	0.000226	CcSEcCtD
Efavirenz—Pruritus—Docetaxel—lung cancer	6.44e-05	0.000225	CcSEcCtD
Efavirenz—Nervous system disorder—Methotrexate—lung cancer	6.43e-05	0.000225	CcSEcCtD
Efavirenz—Anaemia—Doxorubicin—lung cancer	6.43e-05	0.000225	CcSEcCtD
Efavirenz—Thrombocytopenia—Methotrexate—lung cancer	6.42e-05	0.000225	CcSEcCtD
Efavirenz—Agitation—Doxorubicin—lung cancer	6.39e-05	0.000224	CcSEcCtD
Efavirenz—Nausea—Paclitaxel—lung cancer	6.38e-05	0.000223	CcSEcCtD
Efavirenz—Skin disorder—Methotrexate—lung cancer	6.37e-05	0.000223	CcSEcCtD
Efavirenz—Hyperhidrosis—Methotrexate—lung cancer	6.34e-05	0.000222	CcSEcCtD
Efavirenz—Malaise—Doxorubicin—lung cancer	6.27e-05	0.00022	CcSEcCtD
Efavirenz—Vertigo—Doxorubicin—lung cancer	6.25e-05	0.000219	CcSEcCtD
Efavirenz—Anorexia—Methotrexate—lung cancer	6.25e-05	0.000219	CcSEcCtD
Efavirenz—Syncope—Doxorubicin—lung cancer	6.24e-05	0.000218	CcSEcCtD
Efavirenz—Diarrhoea—Docetaxel—lung cancer	6.23e-05	0.000218	CcSEcCtD
Efavirenz—Palpitations—Doxorubicin—lung cancer	6.15e-05	0.000215	CcSEcCtD
Efavirenz—Loss of consciousness—Doxorubicin—lung cancer	6.12e-05	0.000214	CcSEcCtD
Efavirenz—Cough—Doxorubicin—lung cancer	6.07e-05	0.000213	CcSEcCtD
Efavirenz—Convulsion—Doxorubicin—lung cancer	6.03e-05	0.000211	CcSEcCtD
Efavirenz—Dizziness—Docetaxel—lung cancer	6.02e-05	0.000211	CcSEcCtD
Efavirenz—Hypertension—Doxorubicin—lung cancer	6.01e-05	0.00021	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Methotrexate—lung cancer	5.97e-05	0.000209	CcSEcCtD
Efavirenz—Insomnia—Methotrexate—lung cancer	5.93e-05	0.000208	CcSEcCtD
Efavirenz—Myalgia—Doxorubicin—lung cancer	5.92e-05	0.000207	CcSEcCtD
Efavirenz—Chest pain—Doxorubicin—lung cancer	5.92e-05	0.000207	CcSEcCtD
Efavirenz—Arthralgia—Doxorubicin—lung cancer	5.92e-05	0.000207	CcSEcCtD
Efavirenz—Anxiety—Doxorubicin—lung cancer	5.9e-05	0.000207	CcSEcCtD
Efavirenz—Paraesthesia—Methotrexate—lung cancer	5.89e-05	0.000206	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	5.88e-05	0.000206	CcSEcCtD
Efavirenz—Discomfort—Doxorubicin—lung cancer	5.85e-05	0.000205	CcSEcCtD
Efavirenz—Dyspnoea—Methotrexate—lung cancer	5.85e-05	0.000205	CcSEcCtD
Efavirenz—Somnolence—Methotrexate—lung cancer	5.83e-05	0.000204	CcSEcCtD
Efavirenz—Dry mouth—Doxorubicin—lung cancer	5.79e-05	0.000203	CcSEcCtD
Efavirenz—Vomiting—Docetaxel—lung cancer	5.79e-05	0.000203	CcSEcCtD
Efavirenz—Dyspepsia—Methotrexate—lung cancer	5.77e-05	0.000202	CcSEcCtD
Efavirenz—Rash—Docetaxel—lung cancer	5.74e-05	0.000201	CcSEcCtD
Efavirenz—Dermatitis—Docetaxel—lung cancer	5.73e-05	0.000201	CcSEcCtD
Efavirenz—Confusional state—Doxorubicin—lung cancer	5.73e-05	0.0002	CcSEcCtD
Efavirenz—Decreased appetite—Methotrexate—lung cancer	5.7e-05	0.0002	CcSEcCtD
Efavirenz—Headache—Docetaxel—lung cancer	5.7e-05	0.0002	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Methotrexate—lung cancer	5.66e-05	0.000198	CcSEcCtD
Efavirenz—Fatigue—Methotrexate—lung cancer	5.65e-05	0.000198	CcSEcCtD
Efavirenz—Pain—Methotrexate—lung cancer	5.61e-05	0.000196	CcSEcCtD
Efavirenz—Shock—Doxorubicin—lung cancer	5.59e-05	0.000196	CcSEcCtD
Efavirenz—Nervous system disorder—Doxorubicin—lung cancer	5.57e-05	0.000195	CcSEcCtD
Efavirenz—Thrombocytopenia—Doxorubicin—lung cancer	5.56e-05	0.000195	CcSEcCtD
Efavirenz—Tachycardia—Doxorubicin—lung cancer	5.54e-05	0.000194	CcSEcCtD
Efavirenz—Skin disorder—Doxorubicin—lung cancer	5.52e-05	0.000193	CcSEcCtD
Efavirenz—Hyperhidrosis—Doxorubicin—lung cancer	5.49e-05	0.000192	CcSEcCtD
Efavirenz—Anorexia—Doxorubicin—lung cancer	5.41e-05	0.00019	CcSEcCtD
Efavirenz—Nausea—Docetaxel—lung cancer	5.4e-05	0.000189	CcSEcCtD
Efavirenz—Feeling abnormal—Methotrexate—lung cancer	5.4e-05	0.000189	CcSEcCtD
Efavirenz—Gastrointestinal pain—Methotrexate—lung cancer	5.36e-05	0.000188	CcSEcCtD
Efavirenz—Urticaria—Methotrexate—lung cancer	5.21e-05	0.000182	CcSEcCtD
Efavirenz—Abdominal pain—Methotrexate—lung cancer	5.18e-05	0.000181	CcSEcCtD
Efavirenz—Body temperature increased—Methotrexate—lung cancer	5.18e-05	0.000181	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.17e-05	0.000181	CcSEcCtD
Efavirenz—Insomnia—Doxorubicin—lung cancer	5.14e-05	0.00018	CcSEcCtD
Efavirenz—Paraesthesia—Doxorubicin—lung cancer	5.1e-05	0.000179	CcSEcCtD
Efavirenz—Dyspnoea—Doxorubicin—lung cancer	5.06e-05	0.000177	CcSEcCtD
Efavirenz—Somnolence—Doxorubicin—lung cancer	5.05e-05	0.000177	CcSEcCtD
Efavirenz—Dyspepsia—Doxorubicin—lung cancer	5e-05	0.000175	CcSEcCtD
Efavirenz—Decreased appetite—Doxorubicin—lung cancer	4.94e-05	0.000173	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Doxorubicin—lung cancer	4.9e-05	0.000172	CcSEcCtD
Efavirenz—Fatigue—Doxorubicin—lung cancer	4.9e-05	0.000171	CcSEcCtD
Efavirenz—Pain—Doxorubicin—lung cancer	4.86e-05	0.00017	CcSEcCtD
Efavirenz—Constipation—Doxorubicin—lung cancer	4.86e-05	0.00017	CcSEcCtD
Efavirenz—Hypersensitivity—Methotrexate—lung cancer	4.83e-05	0.000169	CcSEcCtD
Efavirenz—Asthenia—Methotrexate—lung cancer	4.71e-05	0.000165	CcSEcCtD
Efavirenz—Feeling abnormal—Doxorubicin—lung cancer	4.68e-05	0.000164	CcSEcCtD
Efavirenz—Gastrointestinal pain—Doxorubicin—lung cancer	4.64e-05	0.000163	CcSEcCtD
Efavirenz—Pruritus—Methotrexate—lung cancer	4.64e-05	0.000162	CcSEcCtD
Efavirenz—Urticaria—Doxorubicin—lung cancer	4.51e-05	0.000158	CcSEcCtD
Efavirenz—Body temperature increased—Doxorubicin—lung cancer	4.49e-05	0.000157	CcSEcCtD
Efavirenz—Abdominal pain—Doxorubicin—lung cancer	4.49e-05	0.000157	CcSEcCtD
Efavirenz—Diarrhoea—Methotrexate—lung cancer	4.49e-05	0.000157	CcSEcCtD
Efavirenz—Dizziness—Methotrexate—lung cancer	4.34e-05	0.000152	CcSEcCtD
Efavirenz—Hypersensitivity—Doxorubicin—lung cancer	4.18e-05	0.000146	CcSEcCtD
Efavirenz—Vomiting—Methotrexate—lung cancer	4.17e-05	0.000146	CcSEcCtD
Efavirenz—Rash—Methotrexate—lung cancer	4.13e-05	0.000145	CcSEcCtD
Efavirenz—Dermatitis—Methotrexate—lung cancer	4.13e-05	0.000145	CcSEcCtD
Efavirenz—Headache—Methotrexate—lung cancer	4.11e-05	0.000144	CcSEcCtD
Efavirenz—Asthenia—Doxorubicin—lung cancer	4.07e-05	0.000143	CcSEcCtD
Efavirenz—Pruritus—Doxorubicin—lung cancer	4.02e-05	0.000141	CcSEcCtD
Efavirenz—Nausea—Methotrexate—lung cancer	3.9e-05	0.000136	CcSEcCtD
Efavirenz—Diarrhoea—Doxorubicin—lung cancer	3.89e-05	0.000136	CcSEcCtD
Efavirenz—Dizziness—Doxorubicin—lung cancer	3.76e-05	0.000131	CcSEcCtD
Efavirenz—Vomiting—Doxorubicin—lung cancer	3.61e-05	0.000126	CcSEcCtD
Efavirenz—Rash—Doxorubicin—lung cancer	3.58e-05	0.000125	CcSEcCtD
Efavirenz—Dermatitis—Doxorubicin—lung cancer	3.58e-05	0.000125	CcSEcCtD
Efavirenz—Headache—Doxorubicin—lung cancer	3.56e-05	0.000125	CcSEcCtD
Efavirenz—Nausea—Doxorubicin—lung cancer	3.37e-05	0.000118	CcSEcCtD
Efavirenz—CYP2D6—Metabolism—AKR1C1—lung cancer	1.72e-05	0.000157	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AKR1C1—lung cancer	1.7e-05	0.000156	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTM2—lung cancer	1.69e-05	0.000155	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CNDP2—lung cancer	1.69e-05	0.000155	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—UGT1A1—lung cancer	1.67e-05	0.000153	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALDOA—lung cancer	1.66e-05	0.000152	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP2E1—lung cancer	1.66e-05	0.000152	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—B4GALT5—lung cancer	1.66e-05	0.000152	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—UGT1A1—lung cancer	1.65e-05	0.000151	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MTMR3—lung cancer	1.64e-05	0.000151	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—NQO1—lung cancer	1.64e-05	0.000151	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTA4—lung cancer	1.62e-05	0.000148	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NCOA3—lung cancer	1.62e-05	0.000148	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GNG11—lung cancer	1.61e-05	0.000147	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PGAM1—lung cancer	1.6e-05	0.000147	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GNG11—lung cancer	1.59e-05	0.000146	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.59e-05	0.000145	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.59e-05	0.000145	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.58e-05	0.000145	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTA2—lung cancer	1.57e-05	0.000144	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ABCG2—lung cancer	1.57e-05	0.000144	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ADCY1—lung cancer	1.57e-05	0.000144	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—HPGDS—lung cancer	1.54e-05	0.000141	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ENO2—lung cancer	1.54e-05	0.000141	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PPP2R1B—lung cancer	1.53e-05	0.00014	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALDOA—lung cancer	1.53e-05	0.00014	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2A7—lung cancer	1.53e-05	0.00014	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTA1—lung cancer	1.52e-05	0.000139	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALDOA—lung cancer	1.52e-05	0.000139	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.51e-05	0.000138	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ABCC3—lung cancer	1.5e-05	0.000138	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SDC4—lung cancer	1.5e-05	0.000137	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTT1—lung cancer	1.49e-05	0.000137	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NCOA3—lung cancer	1.49e-05	0.000136	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—STK11—lung cancer	1.48e-05	0.000136	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GCLC—lung cancer	1.48e-05	0.000135	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP2A6—lung cancer	1.48e-05	0.000135	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NCOA3—lung cancer	1.47e-05	0.000135	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.47e-05	0.000135	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AKR1C1—lung cancer	1.45e-05	0.000133	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.45e-05	0.000133	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ADCY1—lung cancer	1.45e-05	0.000132	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ABCG2—lung cancer	1.45e-05	0.000132	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ADCY1—lung cancer	1.43e-05	0.000131	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ABCG2—lung cancer	1.43e-05	0.000131	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—HPGDS—lung cancer	1.42e-05	0.00013	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ENO2—lung cancer	1.42e-05	0.00013	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—UGT1A1—lung cancer	1.41e-05	0.000129	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.41e-05	0.000129	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—HPGDS—lung cancer	1.4e-05	0.000129	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ENO2—lung cancer	1.4e-05	0.000129	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ENO1—lung cancer	1.4e-05	0.000128	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.4e-05	0.000128	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.4e-05	0.000128	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.38e-05	0.000126	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.38e-05	0.000126	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTT1—lung cancer	1.37e-05	0.000126	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTP1—lung cancer	1.37e-05	0.000126	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTA3—lung cancer	1.36e-05	0.000125	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—RRM1—lung cancer	1.36e-05	0.000125	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTT1—lung cancer	1.36e-05	0.000125	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GNG11—lung cancer	1.36e-05	0.000125	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP2A6—lung cancer	1.36e-05	0.000125	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GCLC—lung cancer	1.36e-05	0.000125	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.35e-05	0.000124	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP2A6—lung cancer	1.35e-05	0.000123	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GCLC—lung cancer	1.35e-05	0.000123	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.34e-05	0.000123	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CAT—lung cancer	1.33e-05	0.000122	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ABCB1—lung cancer	1.3e-05	0.000119	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALDOA—lung cancer	1.3e-05	0.000119	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ENO1—lung cancer	1.29e-05	0.000118	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—B4GALT5—lung cancer	1.28e-05	0.000117	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ENO1—lung cancer	1.28e-05	0.000117	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—TYMS—lung cancer	1.27e-05	0.000117	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.27e-05	0.000117	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTM1—lung cancer	1.26e-05	0.000115	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NCOA3—lung cancer	1.26e-05	0.000115	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP2E1—lung cancer	1.26e-05	0.000115	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.26e-05	0.000115	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTA4—lung cancer	1.25e-05	0.000114	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NQO1—lung cancer	1.24e-05	0.000114	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.24e-05	0.000113	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ABCG2—lung cancer	1.22e-05	0.000112	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ADCY1—lung cancer	1.22e-05	0.000112	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.22e-05	0.000111	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTA2—lung cancer	1.21e-05	0.000111	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.2e-05	0.00011	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HPGDS—lung cancer	1.2e-05	0.00011	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ENO2—lung cancer	1.2e-05	0.00011	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP1A1—lung cancer	1.19e-05	0.000109	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PPP2R1B—lung cancer	1.19e-05	0.000109	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ERCC2—lung cancer	1.18e-05	0.000109	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.18e-05	0.000108	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTA1—lung cancer	1.17e-05	0.000107	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTT1—lung cancer	1.16e-05	0.000107	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCC3—lung cancer	1.16e-05	0.000106	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP2E1—lung cancer	1.16e-05	0.000106	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GCLC—lung cancer	1.15e-05	0.000105	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP2A6—lung cancer	1.15e-05	0.000105	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.15e-05	0.000105	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP2E1—lung cancer	1.15e-05	0.000105	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NQO1—lung cancer	1.14e-05	0.000105	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NQO1—lung cancer	1.13e-05	0.000104	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AKR1C1—lung cancer	1.12e-05	0.000103	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—STK11—lung cancer	1.12e-05	0.000103	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.11e-05	0.000102	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.1e-05	0.000101	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ENO1—lung cancer	1.09e-05	0.0001	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—UGT1A1—lung cancer	1.09e-05	9.99e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.09e-05	9.96e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.07e-05	9.84e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.05e-05	9.63e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GNG11—lung cancer	1.05e-05	9.63e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTP1—lung cancer	1.04e-05	9.49e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—STK11—lung cancer	1.03e-05	9.44e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—APOA1—lung cancer	1.02e-05	9.39e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—STK11—lung cancer	1.02e-05	9.36e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CAT—lung cancer	1.01e-05	9.24e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	1e-05	9.18e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALDOA—lung cancer	1e-05	9.17e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ABCB1—lung cancer	9.81e-06	8.99e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP2E1—lung cancer	9.79e-06	8.97e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NCOA3—lung cancer	9.71e-06	8.9e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NQO1—lung cancer	9.68e-06	8.87e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—TYMS—lung cancer	9.63e-06	8.83e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	9.58e-06	8.78e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTP1—lung cancer	9.53e-06	8.73e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTM1—lung cancer	9.52e-06	8.72e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.48e-06	8.68e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCG2—lung cancer	9.45e-06	8.66e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ADCY1—lung cancer	9.45e-06	8.66e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTP1—lung cancer	9.44e-06	8.66e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.39e-06	8.6e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CG—lung cancer	9.35e-06	8.57e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CAT—lung cancer	9.27e-06	8.5e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HPGDS—lung cancer	9.27e-06	8.49e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ENO2—lung cancer	9.27e-06	8.49e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PPP2R1B—lung cancer	9.21e-06	8.44e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CAT—lung cancer	9.19e-06	8.42e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	9.14e-06	8.37e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP1A1—lung cancer	9.02e-06	8.27e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ABCB1—lung cancer	9.02e-06	8.27e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTT1—lung cancer	8.99e-06	8.24e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ERCC2—lung cancer	8.95e-06	8.2e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ABCB1—lung cancer	8.94e-06	8.19e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—POMC—lung cancer	8.9e-06	8.16e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GCLC—lung cancer	8.88e-06	8.14e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2A6—lung cancer	8.88e-06	8.14e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—TYMS—lung cancer	8.86e-06	8.12e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—TYMS—lung cancer	8.78e-06	8.05e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTM1—lung cancer	8.75e-06	8.02e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—STK11—lung cancer	8.72e-06	7.99e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTM1—lung cancer	8.68e-06	7.95e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CREBBP—lung cancer	8.67e-06	7.95e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ENO1—lung cancer	8.42e-06	7.72e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP1A1—lung cancer	8.3e-06	7.61e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ERCC2—lung cancer	8.23e-06	7.54e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP1A1—lung cancer	8.23e-06	7.54e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CD—lung cancer	8.22e-06	7.54e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.19e-06	7.5e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ERCC2—lung cancer	8.16e-06	7.48e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ALB—lung cancer	8.12e-06	7.44e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTP1—lung cancer	8.07e-06	7.4e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CAT—lung cancer	7.85e-06	7.2e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.81e-06	7.16e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—APOA1—lung cancer	7.74e-06	7.1e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ABCB1—lung cancer	7.64e-06	7e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2E1—lung cancer	7.55e-06	6.92e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—TYMS—lung cancer	7.5e-06	6.88e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NQO1—lung cancer	7.47e-06	6.84e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTM1—lung cancer	7.42e-06	6.8e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.41e-06	6.79e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CB—lung cancer	7.17e-06	6.57e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—APOA1—lung cancer	7.12e-06	6.53e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTGS2—lung cancer	7.1e-06	6.51e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CG—lung cancer	7.07e-06	6.48e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—APOA1—lung cancer	7.06e-06	6.47e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP1A1—lung cancer	7.03e-06	6.44e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ERCC2—lung cancer	6.97e-06	6.39e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.76e-06	6.2e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—STK11—lung cancer	6.73e-06	6.17e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—POMC—lung cancer	6.73e-06	6.17e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CREBBP—lung cancer	6.55e-06	6.01e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CG—lung cancer	6.5e-06	5.96e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CG—lung cancer	6.44e-06	5.91e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTP1—lung cancer	6.23e-06	5.71e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CD—lung cancer	6.21e-06	5.69e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTEN—lung cancer	6.19e-06	5.68e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—POMC—lung cancer	6.19e-06	5.67e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—POMC—lung cancer	6.13e-06	5.62e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALB—lung cancer	6.13e-06	5.62e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CAT—lung cancer	6.06e-06	5.56e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—APOA1—lung cancer	6.03e-06	5.53e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CREBBP—lung cancer	6.03e-06	5.52e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CREBBP—lung cancer	5.98e-06	5.48e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—EP300—lung cancer	5.91e-06	5.41e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCB1—lung cancer	5.9e-06	5.4e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—TYMS—lung cancer	5.79e-06	5.31e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.78e-06	5.29e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTM1—lung cancer	5.72e-06	5.25e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CD—lung cancer	5.71e-06	5.24e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CD—lung cancer	5.67e-06	5.19e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALB—lung cancer	5.64e-06	5.17e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALB—lung cancer	5.59e-06	5.13e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CG—lung cancer	5.51e-06	5.05e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP1A1—lung cancer	5.43e-06	4.97e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CB—lung cancer	5.42e-06	4.96e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ERCC2—lung cancer	5.38e-06	4.93e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTGS2—lung cancer	5.37e-06	4.92e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—POMC—lung cancer	5.24e-06	4.8e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CREBBP—lung cancer	5.11e-06	4.68e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CB—lung cancer	4.98e-06	4.57e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CB—lung cancer	4.94e-06	4.53e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTGS2—lung cancer	4.94e-06	4.52e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTGS2—lung cancer	4.89e-06	4.48e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CD—lung cancer	4.84e-06	4.44e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALB—lung cancer	4.78e-06	4.38e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTEN—lung cancer	4.68e-06	4.29e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOA1—lung cancer	4.66e-06	4.27e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—EP300—lung cancer	4.46e-06	4.09e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CA—lung cancer	4.37e-06	4e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTEN—lung cancer	4.3e-06	3.95e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTEN—lung cancer	4.27e-06	3.91e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CG—lung cancer	4.25e-06	3.9e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CB—lung cancer	4.22e-06	3.87e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTGS2—lung cancer	4.18e-06	3.83e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—EP300—lung cancer	4.1e-06	3.76e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—EP300—lung cancer	4.07e-06	3.73e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—POMC—lung cancer	4.05e-06	3.71e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CREBBP—lung cancer	3.94e-06	3.61e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CD—lung cancer	3.74e-06	3.42e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALB—lung cancer	3.69e-06	3.38e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTEN—lung cancer	3.65e-06	3.34e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—AKT1—lung cancer	3.57e-06	3.27e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—EP300—lung cancer	3.48e-06	3.19e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CA—lung cancer	3.3e-06	3.03e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CB—lung cancer	3.26e-06	2.98e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTGS2—lung cancer	3.23e-06	2.96e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CA—lung cancer	3.04e-06	2.78e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CA—lung cancer	3.01e-06	2.76e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTEN—lung cancer	2.81e-06	2.58e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—AKT1—lung cancer	2.7e-06	2.47e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—EP300—lung cancer	2.68e-06	2.46e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CA—lung cancer	2.57e-06	2.36e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—AKT1—lung cancer	2.48e-06	2.27e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AKT1—lung cancer	2.46e-06	2.25e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AKT1—lung cancer	2.1e-06	1.93e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CA—lung cancer	1.99e-06	1.82e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AKT1—lung cancer	1.62e-06	1.49e-05	CbGpPWpGaD
